Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Auric Goldfinger's Short List -- Ignore unavailable to you. Want to Upgrade?

To: RockyBalboa who wrote (6287)	10/3/2000 7:08:00 PM
From: RockyBalboa	Respond to of 19428

U.S. stocks to watch Calico Commerce (CLIC: news, msgs) said that its second-quarter revenue and operating results will fall below market expectations after the company failed to close several large deals late in the quarter. The company will report operating loss per share for the second-quarter between 33 cents and 43 cents, the company said, compared to a loss of 23 cents in the year-ago quarter. Analysts surveyed by First Call expected the company to post a per-share loss of 15 cents in the second quarter. Ahead of the news, the stock fell 94 cents, or 15.3 percent, to close at $5.19. See full story. Carrier Access (CACS: news, msgs) said third-quarter earnings will be 15 cents to 18 cents per share on revenue of $38 million to $40.5 million. Analysts surveyed by First Call had been expecting earnings of 32 cents per share, on average. According to a company statement, several anticipated sales did not close and sales were weak to Carrier's local telephone company customers. Shares closed up 94 cents to $20.88. Guidant (GDT: news, msgs) said third-quarter earnings of 40 cents per share "may be attainable," according to a company statement. Sales are expected to be $600 million. Also, Guidant received FDA marketing approval for its Multi-Link Tetra Coronary Stent System. Guidant shares closed up 57 cents to $68.94. Lante (LNTE: news, msgs) said it's third quarter earnings will be adversely affected due to its dot-com clients "whose funding became uncertain." The company expects a loss of $6 million to $7 million for the quarter, excluding amortization of deferred compensation and tax benefits as well as bad debt expense of roughly $1.7 million. The Internet consulting company expects revenue for the third quarter to be 12 to 15 percent less than the $23.6 million reported for the second quarter. Shares of Lante closed up 6 cents to $4.75. Latitude Communications (LATD: news, msgs) will report revenues between $10 million and $10.5 million for the third quarter. The company expects earnings between 1 cent and 2 cents a share, compared with a consensus estimate of 4 cents a share. Last year, the company reported a gain of 4 cents per share during the comparable period. Shares of Latitude closed up 9 cents to $7. Metrologic Instruments (MTLG: news, msgs) said third-quarter earnings will be 5 cents to 7 cents per share on revenue of $22.5 million to $22.7 million. One analyst surveyed by First Call expects earnings of 21 cent and another analyst expects earnings of 22 cents per share. According to a company statement, the falling euro knocked 14 cents per share off earnings and $1.3 million from sales. Other problem areas: automation delays and sales delays. Shares were halted up 56 cents to $10.06. Saga Systems (AGS: news, msgs) announced that earnings for the third quarter will be slower than expected due to transactions that failed to close in the last days of the quarter and softness in the Mexican and Canadian markets. The company expects to report earnings per share between 2 to 4 cents, prior to an anticipated one-time $2.0 million charge for settlement of a lawsuit. A survey of analysts by First Call had expected a gain of 17 cents. Revenues will be between $42 million and $44 million. Shares of Sega closed down $2.37, or 22 percent, to $8.18. Thoratec Laboratories (THOR: news, msgs) said Tuesday it would acquire Thermo Cardiosystems (TCA: news, msgs) in a stock swap valued at $571.5 million. Thoratec also warned it won't match analysts third-quarter earnings estimates, citing a summer slowdown resulting in lower-than-expected revenue. Thoratec expects to break even, excluding one-time charges, compared with a loss of 4 cents a share the same period a year ago. A survey of analysts by First Call had expected a profit of 1 cent a share. The merger agreement announced after the closing bell values Thermo Cardiosystems stock at $14.82, a premium of 43 percent based on Tuesday's closing stock prices. Under the pact, Thermo Cardiosystems shareholders would get 0.835 shares of newly issued Thoratec stock for each of their shares. See full story.